1. Home
  2. KRUS vs VOGX Comparison

KRUS vs VOGX Comparison

Compare KRUS & VOGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Sushi USA Inc.

KRUS

Kura Sushi USA Inc.

N/A

Current Price

$23.20

Market Cap

459.1M

ML Signal

N/A

Logo Vogenx Inc Common Stock

VOGX

Vogenx Inc Common Stock

N/A

Current Price

$12.72

Market Cap

482.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRUS
VOGX
Founded
2008
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
459.1M
482.8M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
KRUS
VOGX
Price
$23.20
$12.72
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $43.86
N/A
AVG Volume (30 Days)
★ 297.5K
73.8K
Earning Date
01-06-2027
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $328,276,000.00
N/A
Revenue This Year
$15.09
N/A
Revenue Next Year
$17.22
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 16.10
N/A
52 Week Low
$23.47
$12.61
52 Week High
$80.84
$38.41

Technical Indicators

Market Signals
Indicator
KRUS
VOGX
Relative Strength Index (RSI) 28.55 33.92
Support Level N/A N/A
Resistance Level $59.30 $22.10
Average True Range (ATR) 2.18 2.36
MACD -0.66 -0.60
Stochastic Oscillator 0.03 12.88

Price Performance

Historical Comparison
KRUS
VOGX

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.

About VOGX Vogenx Inc Common Stock

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

Share on Social Networks: